CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 7,100 shares, a growth of 14.5% from the September 30th total of 6,200 shares. Based on an average daily trading volume, of 59,900 shares, the days-to-cover ratio is presently 0.1 days.
CSPC Pharmaceutical Group Price Performance
OTCMKTS:CSPCY opened at C$3.07 on Thursday. The stock has a 50-day simple moving average of C$2.81 and a two-hundred day simple moving average of C$3.05. CSPC Pharmaceutical Group has a 52-week low of C$2.25 and a 52-week high of C$3.82.
CSPC Pharmaceutical Group Increases Dividend
The firm also recently declared a dividend, which will be paid on Thursday, December 5th. Stockholders of record on Friday, November 1st will be issued a $0.0575 dividend. This is an increase from CSPC Pharmaceutical Group’s previous dividend of $0.06. The ex-dividend date of this dividend is Friday, November 1st.
About CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, North America, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments.
Featured Stories
- Five stocks we like better than CSPC Pharmaceutical Group
- What does consumer price index measure?
- Silver Stocks, ETFs, or Bullion: What’s the Best Bet Now?
- What is the NASDAQ Stock Exchange?
- Applied Materials vs ASML: Which is the Best Chip Stock to Own?
- Stock Analyst Ratings and Canadian Analyst Ratings
- Top Bill Gates Stock Picks Every Investor Should Know About
Receive News & Ratings for CSPC Pharmaceutical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSPC Pharmaceutical Group and related companies with MarketBeat.com's FREE daily email newsletter.